CoChat

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk

Open access
Abdalqadir, Nyan, Adeli, Khosrow · 2022 · Microorganisms

The DOI matches its Crossref record; 213 of the 216 references it cites were found in a registry or an index.

Abstract

The intestine represents the body’s largest interface between internal organs and external environments except for its nutrient and fluid absorption functions. It has the ability to sense numerous endogenous and exogenous signals from both apical and basolateral surfaces and respond through endocrine and neuronal signaling to maintain metabolic homeostasis and energy expenditure. The intestine also harbours the largest population of microbes that interact with the host to maintain human health and diseases. Furthermore, the gut is known as the largest endocrine gland, secreting over 100 peptides and other molecules that act as signaling molecules to regulate human nutrition and physiology. Among these gut-derived hormones, glucagon-like peptide 1 (GLP-1) and -2 have received the most attention due to their critical role in intestinal function and food absorption as well as their application as key drug targets. In this review, we highlight the current state of the literature that has brought into light the importance of GLP-1 and GLP-2 in orchestrating intestine–microbiota–immune system crosstalk to maintain intestinal barrier integrity, inflammation, and metabolic homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/microorganisms10102061

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 GLP-1 and GLP-2 signaling and the interaction with the gut inflammatory network and gut microbiota. (A) GLP-1 and 2 are produced by L-cells via enzyme-mediated cleavage of proglucagon. These gut peptides exert diverse effects through binding to their specific receptors, GLP-1R and GLP-2R, respectively. (B) Intestine-specific functions of GLP-1 and -2 are essential to maintain intestine–microbiota–immune system interactions. Created with BioRender.com.
Figure 1 GLP-1 and GLP-2 signaling and the interaction with the gut inflammatory network and gut microbiota. (A) GLP-1 and 2 are produced by L-cells via enzyme-mediated cleavage of proglucagon. These gut peptides exert diverse effects through binding to their specific receptors, GLP-1R and GLP-2R, respectively. (B) Intestine-specific functions of GLP-1 and -2 are essential to maintain intestine–microbiota–immune system interactions. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 119

Metadata

Authors
Abdalqadir, N., & Adeli, K.
Affiliations
University of Toronto (CA)
Corresponding author
Adeli, Khosrow
Venue
Microorganisms
Publisher
MDPI AG
Published
2022-10-19
Volume
10
Issue
10
Pages
2061
ISSN
2076-2607 (ISSN-L)
OpenAlex
W4306848286
Cited by
119
References
216
Citations by year
2026: 36 · 2025: 38 · 2024: 36 · 2023: 8 · 2022: 1
FWCI
2.16
Type
journal article
Language
en
Open access
Locations
  • Microorganisms (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institute of Health Research (CIHR) (FDN-148396)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
glucagon-like peptide-1, glucagon-like peptide-2, intestinal barrier integrity, gut microbiota, intestinal immunity, gut-brain-microbiota axis, intestinal inflammation, metabolic homeostasis, gastrointestinal hormones, intestinal endocrine cells, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.